SAN DIEGO, March 12 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company will present at the Lehman Brothers 11th Annual Global Healthcare Conference in Miami Beach on March 18, 2008 at approximately 3:15 p.m. Eastern Time, and at the Cowen and Company 28th Annual Healthcare Conference in Boston on March 19, 2008 at approximately 8:00 a.m. Eastern Time. Both presentations are scheduled to be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at http://www.gen-probe.com. The webcasts will be available for 30 days following the events.
Gen-Probe Incorporated is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid tests (NATs) that are used primarily to diagnose human diseases and screen donated human blood. Gen-Probe has approximately 25 years of NAT expertise, and received the 2004 National Medal of Technology, America's highest honor for technological innovation, for developing NAT assays for blood screening. Gen-Probe is headquartered in San Diego and employs approximately 1,000 people. For more information, go to http://www.gen-probe.com.
Caution Regarding Forward-Looking Statements
Any statements in this press release about our expectations, beliefs,
plans, objectives, assumptions or future events or performance are not
historical facts and are forward-looking statements. Forward-looking
statements are not guarantees of performance. They involve known and
unknown risks, uncertainties and assumptions that may cause actual results,
levels of ac
|SOURCE Gen-Probe Incorporated|
Copyright©2008 PR Newswire.
All rights reserved